Keppra XR Related Published Studies
Well-designed clinical trials related to Keppra XR (Levetiracetam)
Levetiracetam in the treatment of alcohol dependence: toward the end of the
story? [2012]
A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam
extended-release in very heavy drinking alcohol-dependent patients. [2012]
Double-masked, placebo-controlled study of intravenous levetiracetam for the
treatment of status epilepticus and acute repetitive seizures in dogs. [2012]
A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease. [2011.07]
The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial. [2011.07]
Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial. [2011.06]
Evaluation of the subjective and reinforcing effects of diphenhydramine, levetiracetam, and valproic acid. [2011.06]
The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy. [2011.05]
A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target. [2011.05]
A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. [2011.04]
Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]). [2011.04]
Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease. [2011.02.01]
Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam. [2011.02]
Spotlight on levetiracetam in epilepsy. [2011]
Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's
disease. [2011]
A multicenter, randomized, placebo-controlled trial of levetiracetam in children
and adolescents with newly diagnosed absence epilepsy. [2011]
Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial. [2010.12]
Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial. [2010.11]
Intramuscular and intravenous levetiracetam in humans: safety and pharmacokinetics. [2010.10]
Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers. [2010.09]
An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia. [2010.09]
Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial. [2010.08.29]
Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial. [2010.07]
Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. [2010.05]
Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease. [2010.04]
Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. [2010.04]
Assessment of behavioral and emotional functioning using standardized instruments
in children and adolescents with partial-onset seizures treated with adjunctive
levetiracetam in a randomized, placebo-controlled trial. [2010]
Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures
and Alzheimer's disease. [2010]
Levetiracetam in generalized social anxiety disorder: a double-blind, randomized
controlled trial. [2010]
Levetiracetam in spinal cord injury pain: a randomized controlled trial. [2009.12]
Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. [2009.11]
Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques. [2009.10]
Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: A randomized, double-blind, placebo-controlled, noninferiority trial. [2009.08.21]
Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies. [2009.07]
Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. [2009.07]
Levetiracetam in spinal cord injury pain: a randomized controlled trial. [2009.06.09]
Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. [2009.06]
Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. [2009.06]
A prospective pilot study of levetiracetam for body dysmorphic disorder. [2009.05]
Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. [2009.05]
Pharmacokinetics of levetiracetam XR 500mg tablets. [2009.04]
Effectiveness of levetiracetam in the treatment of lumbar radiculopathy: an open-label prospective cohort study. [2009.04]
Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. [2009.03]
Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study. [2009.03]
The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis. [2009.03]
Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. [2009.03]
Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures. [2009.03]
Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. [2009]
Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures. [2009]
Bioequivalence of two formulations of levetiracetam. [2008.11]
Levetiracetam in absence epilepsy. [2008.11]
Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. [2008.09.12]
Effect of levetiracetam on the postmastectomy pain syndrome. [2008.08]
Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study. [2008.06]
Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study. [2008.04]
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. [2008.02.19]
Effect of levetiracetam on cardiac repolarization in healthy subjects: A single-dose, randomized, placebo- and active-controlled, four-way crossover study. [2008.02]
Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial. [2008.02]
Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures. [2008.02]
The effects of levetiracetam on alcohol consumption in alcohol-dependent subjects: an open label study. [2008]
Levetiracetam and bleeding disorders. [2007.12]
Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. [2007.11.27]
Levetiracetam is not effective for essential tremor. [2007.11]
Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. [2007.11]
Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. [2007.10.30]
Impact of levetiracetam on mood and cognition during prednisone therapy. [2007.10]
Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine. [2007.10]
A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. [2007.09.15]
Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): An open-label, parallel group trial. [2007.06]
Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects. [2007.05]
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. [2007.02.06]
Well-designed clinical trials possibly related to Keppra XR (Levetiracetam)
Antiepileptic drugs and Tourette syndrome. [2013]
The established status epilepticus trial 2013. [2013]
Retigabine for the adjunctive treatment of adults with partial-onset seizures in
epilepsy with and without secondary generalization : a NICE single technology
appraisal. [2013]
Pharmacotherapy to control behavioral symptoms in children with autism. [2012]
Established status epilepticus treatment trial (ESETT). [2011.10]
A prehospital randomized trial in convulsive status epilepticus. [2011.10]
Canine status epilepticus: a translational platform for human therapeutic trials. [2011.10]
Early treatment after stroke for the prevention of late epileptic seizures: a report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis. [2011.05]
Established status epilepticus treatment trial (ESETT). [2011]
Canine status epilepticus: a translational platform for human therapeutic trials. [2011]
Pharmacotherapeutics of Tourette syndrome and stereotypies in autism. [2010.12]
Should phenytoin or barbiturates be used as second-line anticonvulsant therapy for toxicological seizures? [2010.10]
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. [2010.10]
Effects of antiepileptic drugs on associative LTP-like plasticity in human motor cortex. [2010.10]
Effects of antiepileptic drugs on associative LTP-like plasticity in human motor
cortex. [2010]
Anticonvulsant drugs for pediatric migraine prevention: an evidence-based review. [2009.10]
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. [2007.10]
Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. [2007.07]
The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. [2007.06]
The anaesthetic and intensive care of status epilepticus. [2007.04]
Other research related to Keppra XR (Levetiracetam)
Randomized-controlled trials of levetiracetam as an adjunctive therapy in
epilepsy of multiple seizure types. [2014]
Ineffectiveness of topiramate and levetiracetam in infantile spasms
non-responsive to steroids. Open labeled randomized prospective study. [2013]
The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and
P300 in epileptic patients. [2013]
A prospective multicenter comparison of levetiracetam versus phenytoin for early
posttraumatic seizure prophylaxis. [2013]
Tolerability, safety, and side effects of levetiracetam versus phenytoin in
intravenous and total prophylactic regimen among craniotomy patients: a
prospective randomized study. [2013]
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane
Review. [2012]
Intravenous levetiracetam in acute repetitive seizures and status epilepticus in
children: experience from a children's hospital. [2012]
Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for
seizure prevention. [2012]
Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled
pilot study. [2012]
A randomized, double-blind, placebo-controlled trial of levetiracetam for
dyskinesia in Parkinson's disease. [2011]
|